Five‐Year Clinical and Hemodynamic Evaluation of the Hydra Self‐Expanding Transcatheter Heart Valve in Patients With Severe Aortic Stenosis
The 5-year results from the long-term follow-up cohort of the Hydra CE study established excellent valve durability and sustained hemodynamic performance. The study demonstrated favorable long-term safety and clinical performance of the Hydra THV, with acceptable survival rates at 5-year follow-up.
Authors
- Vilhelmas Bajoras (ORCID: https://orcid.org/0000-0002-0917-1442)
- Sigitas Čėsna (ORCID: https://orcid.org/0000-0001-7254-4099)
- Patrycjusz Stokłosa (ORCID: https://orcid.org/0000-0001-9191-5959)
- D. Pečiuraite
- Giedrius Davidavičius (ORCID: https://orcid.org/0000-0003-4025-2221)
- Sudhir Krishna (ORCID: https://orcid.org/0000-0001-8288-3326)
- M. Dąbrowski
- Adam Witkowski
Institutions
- Vilnius University (LT)
- SMT (India) (IN)
- Institute of Cardiology (PL)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1002/ccd.70536
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00